• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病患者动脉粥样硬化加剧且高密度脂蛋白发生改变。

Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease.

作者信息

van Leuven Sander I, Hezemans Rachel, Levels Johannes H, Snoek Susan, Stokkers Pieter C, Hovingh G Kees, Kastelein John J P, Stroes Erik S, de Groot Eric, Hommes Daan W

机构信息

Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

J Lipid Res. 2007 Dec;48(12):2640-6. doi: 10.1194/jlr.M700176-JLR200. Epub 2007 Sep 22.

DOI:10.1194/jlr.M700176-JLR200
PMID:17890779
Abstract

A chronic inflammatory state is a risk factor for accelerated atherogenesis. The aim of our study was to explore whether Crohn's disease (CD), characterized by recurrent inflammatory episodes, is also associated with accelerated atherogenesis. In 60 CD patients and 122 matched controls, carotid intima media thickness (IMT), a validated marker for the burden and progression of atherosclerosis, was assessed ultrasonographically. Additional subgroup analyses, including plasma levels of acute phase reactants and HDL protein profiling, were performed in 11 consecutive patients with CD in remission, 10 patients with active CD, and 15 healthy controls. Carotid IMT in patients with CD was increased compared with healthy volunteers: 0.71 (0.17) versus 0.59 (0.14) mm (P < 0.0001), respectively. In the subgroup analysis, HDL levels in controls and patients in remission were identical [(1.45 (0.48) and 1.40 (0.46) mmol/l; P = 0.797], whereas HDL during exacerbation was profoundly reduced: 1.02 (0.33) (P = 0.022). HDL from patients with active CD and CD patients in remission was characterized by a reduced ability to attenuate oxidation compared with controls (P = 0.008 and P = 0.024 respectively). Patients with CD have increased IMT compared with matched controls, indicative of accelerated atherogenesis. The changes during CD exacerbation in terms of HDL concentration and composition imply a role for impaired HDL protection in these patients.

摘要

慢性炎症状态是动脉粥样硬化加速发展的一个危险因素。我们研究的目的是探讨以反复炎症发作为特征的克罗恩病(CD)是否也与动脉粥样硬化加速发展相关。对60例CD患者和122例匹配的对照者进行超声检查,评估颈动脉内膜中层厚度(IMT),这是一个用于评估动脉粥样硬化负荷和进展的有效指标。对11例连续缓解期的CD患者、10例活动期CD患者和15例健康对照者进行了额外的亚组分析,包括急性期反应物血浆水平和高密度脂蛋白(HDL)蛋白谱分析。与健康志愿者相比,CD患者的颈动脉IMT增加:分别为0.71(0.17)mm和0.59(0.14)mm(P<0.0001)。在亚组分析中,对照组和缓解期患者的HDL水平相同[(1.45(0.48)和1.40(0.46)mmol/L;P =  0.797],而病情加重时HDL水平显著降低:1.02(0.33)(P = 0.022)。与对照组相比,活动期CD患者和缓解期CD患者的HDL减弱氧化的能力降低(分别为P = 0.008和P = 0.024)。与匹配的对照组相比,CD患者的IMT增加,表明动脉粥样硬化加速发展。CD病情加重期间HDL浓度和组成的变化表明HDL保护受损在这些患者中起作用。

相似文献

1
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease.克罗恩病患者动脉粥样硬化加剧且高密度脂蛋白发生改变。
J Lipid Res. 2007 Dec;48(12):2640-6. doi: 10.1194/jlr.M700176-JLR200. Epub 2007 Sep 22.
2
[Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness].[类风湿关节炎中的动脉粥样硬化:高分辨率B型超声在测量动脉内膜中层厚度中的作用]
Reumatismo. 2007 Jan-Mar;59(1):38-49. doi: 10.4081/reumatismo.2007.38.
3
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.血浆磷脂转运蛋白活性升高是2型糖尿病患者颈动脉内膜中层厚度的一个决定因素。
Diabetologia. 2006 Feb;49(2):398-404. doi: 10.1007/s00125-005-0088-0. Epub 2005 Dec 23.
4
Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.原发性抗磷脂综合征中的血管异常、对氧磷酶活性及功能失调的高密度脂蛋白
JAMA. 2009 Sep 16;302(11):1210-7. doi: 10.1001/jama.2009.1346.
5
Intima-media thickness of femoral arteries and carotids among an adult hypertensive Nigerian population: A case-control study to assess their use as surrogate markers of atherosclerosis.尼日利亚成年高血压人群股动脉和颈动脉的内膜中层厚度:一项评估其作为动脉粥样硬化替代标志物用途的病例对照研究。
Ann Afr Med. 2019 Jul-Sep;18(3):158-166. doi: 10.4103/aam.aam_57_18.
6
Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia.原发性低高密度脂蛋白血症患者颈动脉内膜中层厚度增加。
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):317-22. doi: 10.1161/hq0202.104848.
7
No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls.强直性脊柱炎年轻患者与健康对照者的颈动脉内膜中层厚度无差异。
Joint Bone Spine. 2008 Oct;75(5):548-53. doi: 10.1016/j.jbspin.2007.11.007. Epub 2008 May 19.
8
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.炎症性肠病患者早期动脉粥样硬化标志物表达增加。
Eur J Intern Med. 2017 Jan;37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.
9
Imparied retrobulbar blood flow and increased carotid IMT in patients with Crohn's disease.克罗恩病患者球后血流受损及颈动脉内膜中层厚度增加。
Int J Cardiovasc Imaging. 2016 Nov;32(11):1617-1623. doi: 10.1007/s10554-016-0956-3. Epub 2016 Aug 13.
10
Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD.慢性肾脏病患者颈动脉内膜中层厚度与心血管危险因素之间的关联
Am J Kidney Dis. 2005 Nov;46(5):856-62. doi: 10.1053/j.ajkd.2005.07.048.

引用本文的文献

1
Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis.血清脂质与炎症性肠病的关联:一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 Aug 24;10:1198988. doi: 10.3389/fmed.2023.1198988. eCollection 2023.
2
HDL Functions-Current Status and Future Perspectives.高密度脂蛋白的功能——现状与未来展望。
Biomolecules. 2023 Jan 4;13(1):105. doi: 10.3390/biom13010105.
3
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression.靶向三磷酸腺苷结合盒转运体 A1(ABCA1)基因表达的潜在治疗药物。
Drugs. 2022 Jul;82(10):1055-1075. doi: 10.1007/s40265-022-01743-x. Epub 2022 Jul 21.
4
Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.炎症性肠病患者的内皮功能障碍与动脉僵硬度:一项系统评价和荟萃分析
J Clin Med. 2022 Jun 2;11(11):3179. doi: 10.3390/jcm11113179.
5
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.一种新型血清代谢组学panel 可区分 IgG4 相关硬化性胆管炎与原发性硬化性胆管炎。
Liver Int. 2022 Jun;42(6):1344-1354. doi: 10.1111/liv.15192. Epub 2022 Feb 21.
6
Cortical Vein Thrombosis after Infliximab Treatment for Crohn's Disease.英夫利昔单抗治疗克罗恩病后发生的皮质静脉血栓形成
Neurol Int. 2021 Mar 11;13(1):120-124. doi: 10.3390/neurolint13010011.
7
Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets.炎症性肠病中的血管内皮功能障碍:药理和非药理靶点。
Oxid Med Cell Longev. 2018 Apr 12;2018:2568569. doi: 10.1155/2018/2568569. eCollection 2018.
8
Care of inflammatory bowel disease patients in remission.缓解期炎症性肠病患者的护理。
Gastroenterol Rep (Oxf). 2016 Nov;4(4):261-271. doi: 10.1093/gastro/gow032. Epub 2016 Oct 10.
9
Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins.比较基于荧光的无细胞检测方法以评估高密度脂蛋白的抗氧化能力。
Lipids Health Dis. 2016 Sep 22;15(1):163. doi: 10.1186/s12944-016-0336-y.
10
The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.5A载脂蛋白A-I(apoA-I)模拟肽通过调节单核细胞浸润改善实验性结肠炎。
Br J Pharmacol. 2016 Sep;173(18):2780-92. doi: 10.1111/bph.13556. Epub 2016 Aug 11.